Stockreport

Aeterna Zentaris Announces that ZoptEC Phase 3 Clinical Study of Zoptrex™ Did Not Achieve its Primary Endpoint

Aeterna Zentaris Inc.  (AEZS) 
Last aeterna zentaris inc. earnings: 11/7 06:28 pm Check Earnings Report
US:NASDAQ Investor Relations: zentaris.com
PDF Company Expects to Submit Macrilen™ NDA in Third Quarter of 2017 CHARLESTON, S.C.--(BUSINESS WIRE)-- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) [Read more]